https://www.statnews.com/2025/11/17/nuvalent-alk-lung-cancer-drug-neladalkib-succeeds/
Nuvalent says ALK+ targeted lung cancer drug succeeds in trial | STAT
Nov 17, 2025 - ALK+ lung cancer is a dramatic example of how targeting certain enzymes in tumors can produce dramatic results
lung cancerdrug succeedssays
https://www.biopharmadive.com/news/novartis-lutathera-first-line-cancer-study-success/694606/
Novartis radiopharmaceutical drug succeeds in first-line gut cancer study | BioPharma Dive
Novartis has made a large investment in targeted radiotherapies, sparking competition from fellow pharma companies and young biotechs.
drug succeedsfirst linegut
https://www.statnews.com/2025/12/08/kymera-kt-621-clinical-trial-results-atopic-dermatitis-challenge-dupixent/
Kymera eczema drug succeeds in early trial, could rival Dupixent | STAT
Dec 8, 2025 - Now, Kymera will aim to show its experimental drug helps patients with eczema and asthma in larger clinical trials.
eczema drugearly trialkymera
https://www.statnews.com/2025/12/03/hair-loss-drug-succeeds-phase-3-trial-cosmo-pharmaceuticals/
Hair loss drug by Cosmo Pharmaceuticals succeeds in Phase 3 trial | STAT
Dec 3, 2025 - The topical medication treats a common form of hair loss called androgenetic alopecia.
hair lossdrugcosmosucceeds